News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
233 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17922)
Month
January (4681)
February (5218)
March (5801)
April (5233)
May (5822)
June (5224)
July (4072)
August (4645)
September (4519)
October (4153)
November (5533)
December (3823)
Day
1 (356)
2 (311)
3 (275)
4 (220)
5 (5)
6 (13)
7 (269)
8 (259)
9 (234)
10 (254)
11 (151)
12 (8)
13 (5)
14 (231)
15 (262)
16 (229)
17 (233)
18 (106)
19 (13)
20 (5)
21 (200)
22 (226)
23 (228)
24 (236)
25 (117)
26 (12)
27 (4)
28 (256)
29 (245)
30 (261)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Pharm Country
ContraFect Invited to Present New Research Data From Its Pipeline of Direct Lytic Agents at World Microbe Forum
ContraFect Corporation announced multiple presentations, including two oral presentations, of data from its portfolio of DLAs at the 2021 World Microbe Forum, being held virtually from June 20-24, 2021.
June 17, 2021
·
9 min read
Business
Synlogic Enters Research Collaboration with Roche for Development of Novel Therapy to Treat Inflammatory Bowel Disease
Synlogic, Inc. announced today that it has entered into a research collaboration agreement with Roche for the discovery of a novel Synthetic Biotic™ medicine for the treatment of inflammatory bowel disease (IBD).
June 17, 2021
·
3 min read
Biotech Beach
Metacrine and Its Partners to Present Data at the EASL International Liver Congress™ 2021
Metacrine, Inc. today announced that it will present data at the European Association for the Study of the Liver (EASL) International Liver Congress™ 2021, being held virtually from June 23-26, 2021.
June 17, 2021
·
2 min read
BioMidwest
Lilly Launches Think Talk Treat Migraine™ to Help Improve Diagnosis and Treatment of Migraine
Eli Lilly and Company (NYSE: LLY) launched Think Talk Treat Migraine™, a new initiative to empower people living with migraine and their primary care providers to recognize key symptoms of migraine and have better conversations about the disease that can lead to proper diagnosis and treatment.
June 17, 2021
·
9 min read
Business
Lineage Announces Exclusive Option Agreement With Amasa Therapeutics for Supply and Use of Clinical-Grade Hystem®
Lineage Announces Exclusive Option Agreement With Amasa Therapeutics for Supply and Use of Clinical-Grade Hystem,
June 17, 2021
·
9 min read
BioMidwest
Aptinyx to Participate in Upcoming Investor Conferences - June 17, 2021
Aptinyx Inc., a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of nervous system disorders, announced that the Company will be participating in two upcoming investor conferences
June 17, 2021
·
1 min read
Pharm Country
Amneal Announces U.S. FDA Filing Acceptance of Biologics License Application (BLA) for Bevacizumab
Amneal Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for Bevacizumab.
June 17, 2021
·
6 min read
Drug Development
Cyclo Therapeutics Commences Patient Enrollment in TransportNPC, a Pivotal Phase 3 Study Evaluating Trappsol® Cyclo™ in Niemann-Pick Type C1
Cyclo Therapeutics Commences Patient Enrollment in TransportNPC, a Pivotal Phase 3 Study Evaluating Trappsol ® Cyclo™ in Niemann-Pick Type C1.
June 17, 2021
·
7 min read
Drug Development
Histopathology Preclinical Data from ImmunoPrecise’s Polytope™ Program Confirms Lung Inflammation Reduction
IMMUNOPRECISE today announced additional results from its in vivo hamster challenge efficacy study of TATX-03a PolyTope™ Therapy.
June 17, 2021
·
7 min read
BioMidwest
AOAC Approves NEOGEN Soleris® Direct Yeast and Mold for Use in Cannabis
NEOGEN Corporation’s (NASDAQ: NEOG) Soleris® Direct Yeast and Mold test has received the Performance Tested MethodsSM Certification from the AOAC Research Institute’s Emergency Response Validation Process for the enumeration of yeasts and molds in dried cannabis flower [9-tetrahydrocannabinol (THC) >0.3%].
June 17, 2021
·
2 min read
Previous
21 of 24
Next